The American Journal of Managed Care7h
Nipocalimab’s Promising Potential in Advancing gMG Care
For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).
The American Journal of Managed Care14h
Abelacimab Shows Potential to Shift the Standard of Care in AFib
Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.
For the Sick and Dying, Live Music to Ease the Pain
A violinist plays for her father. A singer takes requests. In hospitals and hospices, bedside performers offer a new kind of ...
Science Daily1d
New treatment may offer quick cure for common cause of high blood pressure
A revolutionary new treatment called Targeted Thermal Therapy (Tripel T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal ...
WDRB1d
The 2 sides of Ozempic — weight loss success stories and health nightmares in Kentucky
The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...
Healio1d
BLOG: Who cares about dilation reversal? Patients do
Occasionally, treatments come along that are of greater interest to patients than to doctors.Drops for treating presbyopia ...
News Medical1d
New minimally invasive treatment offers hope for primary aldosteronism
Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of a simple, minimally invasive Targeted Thermal Therapy (Triple T) that has ...